RSV vaccine development for all ages, what lies ahead of us?
On April 26, we presented the webinar: RSV vaccine development for all ages, what lies ahead of us?
In this webinar, Prof. Louis Bont, shared his views on the burden of RSV infections across generations and the latest advancements in monoclonal antibodies and vaccines against RSV.
The webinar was hosted by Leyla Kragten-Tabatabaie.
Watch the replay below:
Related webinars
Webinar- Real-World Evidence in Vaccine Safety: Methods, Challenges, and Opportunities in Multi-Database Studies
On April 10th, 2025, we will organise the webinar: Real-World Evidence in Vaccine Safety: Methods, Challenges, and Opportunities in Multi-Database Studies Why Attend?Expert Insights: Learn from leading professionals in vaccine epidemiolog...
Webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical Trials
On October 26, we presented the webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical TrialsDuring this webinar, our speaker and co-hosts, dived into Decentralized Clinical Trials and discuss the case stu...
Webinar: “RSV and Asthma”
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma”Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
